|
1
|
Kelly NE and Wendel RT: Vitreous surgery
for idiopathic macular holes. Results of a pilot study. Arch
Ophthalmol. 109:654–659. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sheidow TG, Blinder KJ, Holekamp N, Joseph
D, Shah G, Grand MG, Thomas MA, Bakal J and Sharma S: Outcome
results in macular hole surgery: an evaluation of internal limiting
membrane peeling with and without indocyanine green. Ophthalmology.
110:1697–1701. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mester V and Kuhn F: Internal limiting
membrane removal in the management of full-thickness macular holes.
Am J Ophthalmol. 129:769–777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brooks HL Jr: Macular hole surgery with
and without internal limiting membrane peeling. Ophthalmology.
107:1939–1949. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshida M, Otsubo A and Kishi S: Incidence
of reopening of macular hole after successful surgery with removal
of internal limiting membrane. Jap J Clin Ophthal. 56:999–1003.
2002.
|
|
6
|
de Nie KF, Crama N, Tilanus MA, Klevering
BJ and Boon CJ: Pars plana vitrectomy for disturbing primary
vitreous floaters: clinical outcome and patient satisfaction.
Graefes Arch Clin Exp Ophthalmol. 251:1373–1382. 2013.PubMed/NCBI
|
|
7
|
Valldeperas X and Wong D: Is it worth
reoperating on macular holes? Ophthalmology. 115:158–163. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
D’Souza MJ, Chaudhary V, Devenyi R, Kertes
PJ and Lam WC: Re-operation of idiopathic full-thickness macular
holes after initial surgery with internal limiting membrane peel.
Br J Ophthalmol. 95:1564–1567. 2011.PubMed/NCBI
|
|
9
|
Meleth AD, Toy BC, Nigam D, et al:
Prevalence and progression of pigment clumping associated with
idiopathic macular telangiectasia type 2. Retina. 33:762–770. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rezende FA and Kapusta MA: Internal
limiting membrane: ultrastructural relationships, with clinical
implication for macular hole healing. Can J Ophthalmol. 39:251–259.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Steel DH and Lotery AJ: Idiopathic
vitreomacular traction and macular hole: a comprehensive review of
pathophysiology, diagnosis, and treatment. Eye (Lond). 27(Suppl 1):
S1–S21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Christensen UC, Krøyer K, Sander B, Larsen
M, Henning V, Villumsen J and la Cour M: Value of internal limiting
membrane peeling in surgery for idiopathic macular hole stage 2 and
3: a randomised clinical trial. Br J Ophthalmol. 93:1005–1015.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Passemard M, Yakoubi Y, Muselier A, Hubert
I, Guillaubey A, Bron AM, Berrod JP and Creuzot-Garcher C:
Long-term outcome of idiopathic macular hole surgery. Am J
Ophthalmol. 149:120–126. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leonard RE II, Smiddy WE, Flynn HW Jr and
Feuer W: Long-term visual outcomes in patients with successful
macular hole surgery. Ophthalmology. 104:1648–1652. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sanisoglu H, Sevim MS, Aktas B, Sevim S
and Nohutcu A: Outcomes of 23-gauge pars plana vitrectomy and
internal limiting membrane peeling with brilliant blue in macular
hole. Clin Ophthalmol. 5:1177–1183. 2011.PubMed/NCBI
|
|
16
|
Iriyama A, Uchida S, Yanagi Y, Tamaki Y,
Inoue Y, Matsuura K, Kadonosono K and Araie M: Effects of
indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis
Sci. 45:943–947. 2004. View Article : Google Scholar
|
|
17
|
Yip HK, Lai TY, So KF and Kwok AK: Retinal
ganglion cell toxicity caused by photosensitising effects of
intravitreal indocyanine green with illumination in rat eyes. Br J
Ophthalmol. 90:99–102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jackson TL, Hillenkamp J, Knight BC, Zhang
JJ, Thomas D, Stanford MR and Marshall J: Safety testing of
indocyanine green and trypan blue using retinal pigment epithelium
and glial cell cultures. Invest Ophthalmol Vis Sci. 45:2778–2785.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stanescu-Segall D and Jackson TL: Vital
staining with indocyanine green: a review of the clinical and
experimental studies relating to safety. Eye (Lond). 23:504–518.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Beutel J, Dahmen G, Ziegler A and Hoerauf
H: Internal limiting membrane peeling with indocyanine green or
trypan blue in macular hole surgery: a randomized trial. Arch
Ophthalmol. 125:326–332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Terasaki H, Miyake Y, Nomura R, Piao CH,
Hori K, Niwa T and Kondo M: Focal macular ERGs in eyes after
removal of macular ILM during macular hole surgery. Invest
Ophthalmol Vis Sci. 42:229–234. 2001.PubMed/NCBI
|
|
22
|
Kumagai K, Furukawa M, Ogino N, Uemura A,
Demizu S and Larson E: Vitreous surgery with and without internal
limiting membrane peeling for macular hole repair. Retina.
24:721–727. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Freeman WR, Azen SP, Kim JW, el-Haig W,
Mishell DR III and Bailey I: Vitrectomy for the treatment of
full-thickness stage 3 or 4 macular holes. Results of a
multicentered randomized clinical trial. The Vitrectomy for
Treatment of Macular Hole Study Group. Arch Ophthalmol. 115:11–21.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Christensen UC, Krøyer K, Sander B,
Jorgensen TM, Larsen M and la Cour M: Macular morphology and visual
acuity after macular hole surgery with or without internal limiting
membrane peeling. Br J Ophthalmol. 94:41–47. 2010. View Article : Google Scholar : PubMed/NCBI
|
